Virus strain from NIV Pune transferred.

The team members will pay regular visits to these hospitals and send reports to the department, the state government said in an order.

The antigen test is the third type of test to be authorized by the FDA.

Two expatriates test positive in Kerala; Karnataka focuses on Bengaluru cases

The number of novel coronavirus cases recorded worldwide surpassed four million on Saturday, according to an AFP tally based on official sources, as o

The outbreak came just as South Korea has eased some social distancing restrictions and is seeking to fully reopen schools and businesses

Globally, as of 9 May 2020, there have been 3,862,676 confirmed cases, including 265,961 deaths, reported to WHO.

From now on, only those with severe Covid-19 symptoms will need to undergo RT-PCR tests, that too only one and not two consecutive tests that were mandatory earlier, for their release from the hospital after treatment. Covid-positive patients with mild and moderate symptoms will no longer require the mandatory negative confirmatory tests before they are sent home.

Pushkar has become a role model for keeping foreign tourists safe and not a single person has tested positive for Covid-19 in the last two months.

Obama cast the US response to the virus as an outgrowth of tribalism as he sought to emphasise the urgency of the November election

The Bundesliga and Bundesliga 2 are set to be back underway on May 16.

Maharashtra has the highest number of cases with around 20,228 positive cases of infection and 779 deaths.

(This story originally appeared in AhmedabadMirror on May 10, 2020)

The Covid-19 count of Haryana on Saturday reached 675 as 28 new cases, which includes 25 from the national capital region (NCR) were reported. A 22-year-old TB patient also succumbed to Covid-19 in Panipat taking death toll to 9 in the state.

Coronavirus shock: Pandemic lockdowns have changed how the planet SOUNDS and vibrates  Express.co.uk

Coronavirus: Is lockdown an opportunity for scientific research?  sciencefocus.com

Coronavirus: the week explained - 10 April  The Guardian

Explained: How coronavirus lockdown reduced Earth’s seismic noise levels  The Indian Express

Why the UK's streets have turned silent during coronavirus lockdown  Express.co.uk

An instrument on board NASA's Solar Dynamics Observatory, developed by Smithsonian scientists, is giving unprecedented views of the Sun's innermost corona 24 hours a day, 7 days a week.

The post Smithsonian instrument reveals Sun’s innermost corona appeared first on Smithsonian Insider.

A July 12 news alert from NASA indicates a X1.4 class solar flare erupted from the center of the Sun, peaking July 12 at 12:52 P.M.

The post Coronal mass ejection from July 12 solar flare headed toward Earth; minor geomagnetic storm activity predicted appeared first on Smithsonian Insider.

Today, astronomers are releasing the highest-resolution images ever taken of the Sun's corona, or million-degree outer atmosphere, in an extreme-ultraviolet wavelength of light.

The post Astronomers release highest-resolution images ever of the Sun’s corona appeared first on Smithsonian Insider.

But how can the solar atmosphere get hotter, rather than colder, the farther you go from the Sun's surface? A suborbital rocket launched in July provides the answer.

The post HI-C adds big piece to the solar corona puzzle appeared first on Smithsonian Insider.

Why is the Sun’s million-degree corona, or outermost atmosphere, so much hotter than the Sun’s surface? This question has baffled astronomers for decades. Today, a […]

The post Tiny ‘nanoflares’ might heat the Sun’s corona appeared first on Smithsonian Insider.

Mole

Mole is the JCS resident insectivore who shares his views on various aspects of life-science research. In this series, called The Corona Files, Mole talks about how the COVID-19 pandemic is changing the landscape for researchers.

In this article, a framework is presented that allows the systematic derivation of planar edge-to-edge k-isocoronal tilings from tile-s-transitive tilings, s ≤ k. A tiling {cal T} is k-isocoronal if its vertex coronae form k orbits or k transitivity classes under the action of its symmetry group. The vertex corona of a vertex x of {cal T} is used to refer to the tiles that are incident to x. The k-isocoronal tilings include the vertex-k-transitive tilings (k-isogonal) and k-uniform tilings. In a vertex-k-transitive tiling, the vertices form k transitivity classes under its symmetry group. If this tiling consists of regular polygons then it is k-uniform. This article also presents the classification of isocoronal tilings in the Euclidean plane.

Mole
May 1, 2020; 133:jcs247346-jcs247346
STICKY WICKET

The White House Office of Science and Technology Policy (OSTP) this week requested that the National Academies of Sciences, Engineering, and Medicine rapidly examine the information and data needed to help determine the origins of the novel coronavirus that is causing a global outbreak of respiratory illness.

WASHINGTON — In response to the COVID-19 outbreak, the White House Office of Science and Technology Policy has asked the National Academies of Sciences, Engineering, and Medicine to establish a Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats.

The National Academies of Sciences, Engineering, and Medicine announced today that Harvey Fineberg, former president of the Institute of Medicine (now the National Academy of Medicine) and current president of the Gordon and Betty Moore Foundation, will serve as the chair of the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats.

Formed earlier this month, the National Academies’ Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats was assembled at the request of the White House Office of Science and Technology Policy and the Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak.

The recently formed National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, assembled at the request of the White House Office of Science and Technology Policy and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response in response to the COVID-19 outbreak, has been providing rapid expert consultations on several topics, such as social distancing and severe illness in young adults.

National Academy of Medicine President Victor J. Dzau will provide remarks on behalf of the Global Preparedness Monitoring Board during a virtual event on May 4 to launch an online pledging effort, the Coronavirus Global Response.

President Trump walks outside the White House in January. The president received intelligence briefings on the coronavirus twice that month, according to a White House official.; Credit: Saul Loeb/AFP via Getty Images

President Trump twice received intelligence briefings on the coronavirus in January, according to a White House official. The official tells NPR the briefings occurred on Jan. 23 and Jan. 28.

"The president was told that the coronavirus was potentially going to 'spread globally,' " the official said of the first briefing, which came two days after the first case of the virus was reported in the United States. "But the 'good news' was that it was not deadly for most people," the official said the president was told.

Five days after that initial briefing, the president was briefed again, according to the official. This time, "he was told that virus was spreading outside of China, but that deaths from the disease were happening only in China," the official said. "He was also told that China was withholding data."

The question of what Trump knew about the coronavirus, when he was aware of it and the tenor of those conversations have come under heavy scrutiny, as the administration faces criticism that it was slow to respond to early warnings about the virus. In the time since the president's January briefings, the U.S. has reported more than 1.1 million cases of the coronavirus — more than any other nation. In all, more than 66,000 Americans have died.

The president has defended his handling of the crisis — pointing to steps like his decision at the end of January to restrict travel into the U.S. from China. But for much of the following month, the president and some of his top surrogates downplayed the threat of the virus.

"We pretty much shut it down coming in from China," the president said in an interview with Sean Hannity of Fox News early in February. By the end of the month, with the virus reported in several dozen countries at that point, he continued to tell reporters that the risk "remains very low ."

During his State of the Union address, roughly a week after being told that China was withholding data, Trump said his administration was "coordinating with the Chinese government and working closely together on the coronavirus outbreak."

To this point, the White House has offered little clarity publicly about the exact dates when Trump was briefed about the virus. Asked about this on Thursday, Trump told reporters that he spoke with intelligence officials about the coronavirus "in January, later January," adding that intelligence officials had confirmed that this was the case.

On Monday, when The Washington Post reported that Trump received more than a dozen classified briefings in January and February, the Office of the Director of National Intelligence responded, "The detail of this is not true," and declined to elaborate.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Speaker of the House Nancy Pelosi wears a mask on Capitol Hill on April 30. Members in the House will not return over coronavirus fears but the Senate is scheduled to return on Monday.; Credit: Saul Loeb/AFP via Getty Images

House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell, in a rare joint statement on Saturday, declined an offer from the White House to make rapid COVID-19 tests available for Congress.

"Congress is grateful for the Administration's generous offer to deploy rapid COVID-19 testing capabilities to Capitol Hill, but we respectfully decline the offer at this time," Pelosi and McConnell said. "Our country's testing capacities are continuing to scale up nationwide and Congress wants to keep directing resources to the front-line facilities where they can do the most good the most quickly."

McConnell, R-Ky., plans to bring the Senate back into session on Monday, while Pelosi, D-Calif., and House Majority Leader Steny Hoyer, D-Md., said this week the House would not bring representatives back over coronavirus fears.

On Friday, Health and Human Services Secretary Alex Azar said on Twitter that the Trump administration would send three Abbott "point of care testing machines and 1,000 tests for their use" to Capitol Hill.

President Trump on Saturday tweeted: " No reason to turn it down, except politics. We have plenty of testing. Maybe you need a new Doctor over there. Crazy Nancy will use it as an excuse not to show up to work!"

Pelosi and Hoyer said they made the decision based on advice from the Capitol's attending physician, Brian Monahan. "The House physician's view was that there was a risk to members that was one he would not recommend taking," Hoyer said Tuesday.

So far, Rand Paul of Kentucky is the only senator to have tested positive for the coronavirus. In the House, seven members have tested positive or presumed to be positive for the coronavirus.

On Friday, McConnell shared guidelines from Monahan urging lawmakers and staff to maintain six feet of distance, limit the number of people in offices and to wear masks when possible.

Monahan has told Republican leaders that his office does not have the capacity to proactively test all 100 senators and can only test those who are ill, Politico reported.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Rick Bright filed a complaint this week with the Office of Special Counsel, a government agency responsible for whistleblower complaints.; Credit: /Public Health Emergency via AP

Attorneys for Rick Bright, the government scientist who said he had been reassigned and subsequently filed a whistleblower complaint, say a government watchdog agrees that he should be reinstated to his post.

Bright was serving as director of the Biomedical Advanced Research and Development Authority, which is working on a vaccine to combat the coronavirus.

He said he was ousted from the position last month because he wanted to spend money on safe and vetted treatments for COVID-19 — not on ones without "scientific merit," such as hydroxychloroquine, the anti-malarial drug that President Trump and others had been touting.

Trump on Wednesday called Bright "a disgruntled employee who's trying to help the Democrats win an election."

Bright's attorneys say that the Office of Special Counsel, which hears whistleblower cases, determined there were "reasonable grounds" to believe that his removal was retaliatory and therefore prohibited.

Bright's attorneys say OSC plans to contact the Department of Health and Human Services to request that it put Bright's removal on hold for 45 days so the office can complete its investigation into the allegations.

The OSC said it "cannot comment on or confirm the status of open investigations."

In a statement to NPR, Caitlin Oakley, a spokesperson for HHS, said: "This is a personnel matter that is currently under review. However, HHS strongly disagrees with the allegations and characterizations in the complaint from Dr. Bright."

This content is from Southern California Public Radio. View the original story at SCPR.org.

The temperature of a Bolivian child is measured in front of Bolivian embassy during a demonstration requesting repatriation on April 28, 2020 in Santiago, Chile. ; Credit: Marcelo Hernandez/Getty Images

As of Wednesday afternoon, L.A. County has at least 1,367 deaths and 28,646 confirmed cases of coronavirus. Meanwhile, parts of the state are slowly reopening some industries. 

Certain businesses and recreational spaces in Los Angeles County will be allowed to reopen beginning Friday, county officials announced at a media briefing. Those include hiking trails, golf courses, florists, car dealerships and certain retail stores. School districts continue to work through challenges as they consider how to reopen. Kids and teens are coming down with an inflammatory syndrome that experts believe could be linked to COVID-19, NPR News reports. Today on AirTalk, we get the latest on the pandemic with a noted physician, plus we’ll look at the expanding list of symptoms associated with the coronavirus. Are you a parent who has questions about the virus and kids? We want to hear from you. Join the conversation by calling 866-893-5722. 

With files from LAist

Guest:

Richard Jackson, M.D., pediatrician, epidemiologist and professor emeritus at the UCLA Fielding School of Public Health, he’s served in many leadership positions with the California Health Department, including as the State Health Officer, for nine years he served as director of the CDC’s National Center for Environmental Health

This content is from Southern California Public Radio. View the original story at SCPR.org.

February satellite readings in the troposphere (the lower atmosphere) of nitrogen dioxide (NO2), a pollutant primarily from burning fossil fuels, show a dramatic decline compared to early January when power plants were operating at normal levels.; Credit: /NASA Earth Observatory

As China seeks to control the spread of COVID-19, fewer cars are driving, fewer factories are running and — in some places — skies are clearer.

Air pollution levels have dropped by roughly a quarter over the last month as coal-fired power plants and industrial facilities have ramped down so employees in high-risk areas can stay home. Levels of nitrogen dioxide, a pollutant primarily from burning fossil fuels, were down as much as 30%, according to NASA.

"It is an unprecedentedly dramatic drop in emissions," says Lauri Myllyvirta, lead analyst at the Centre for Research on Energy and Clean Air, who tallied the reductions. "I've definitely spoken to people in Shanghai who said that it's been some of the most pristine blue skies that they remember over the winter."

Myllyvirta estimates that China's carbon emissions have dropped by a quarter over the same period. While that's a tiny fraction of its overall annual emissions, it's substantial in a worldwide context, since China is the largest emitter of greenhouse gases.

There's potentially a health benefit — although any gains due to a drop in pollution are set against the toll taken by the coronavirus outbreak.

Air pollution is estimated to contribute to more than 1 million premature deaths in China each year. Fine particle pollution, also known as PM 2.5, can enter the bloodstream through the lungs and has been linked to asthma attacks, heart attacks and respiratory problems.

Even a short-term reduction in air pollution can make a difference.

"There is no question about it: When air quality improves, that will be associated with a reduction in health-related problems," says Jim Zhang, professor of global and environmental health at Duke University.

Zhang says that was evident during the 2008 summer Olympics in Beijing. To help improve the air, government officials shut factories and dramatically limited car travel before and during the games. Levels of some air pollutants dropped by half.

He and colleagues studied a group of young men and women in Beijing and found that during that time period, their lung and cardiovascular health improved. He also followed pregnant women.

"What we found is that the kids whose mothers had a third trimester pregnancy during the Olympics when the air quality was better, their birth weight was substantially higher than the kids who were born a year before and a year later," he says.

But health specialists sound a cautionary note.

"It would be a mischaracterization to say that the coronavirus was beneficial to health because of these air pollution reductions," says Jill Baumgartner, associate professor and epidemiologist at McGill University.

"The health impacts from the virus itself, the stress on the health-care system, the stress on people's lives — those health impacts are likely to be much greater than the short-term benefits of air pollution on health," she says.

Baumgartner says people with health issues other than COVID-19 may have avoided seeing doctors during the outbreak or potentially couldn't receive treatment they needed in areas with overtaxed health systems.

Those isolated at home and avoiding crowds may also have been exposed to more indoor air pollution.

"People spent a lot more time indoors and it's possible that they were exposed to higher levels of indoor tobacco smoke," Baumgartner says. "Or in the suburban areas, it's possible that they were using their traditional wood or coal stoves for heating."

Not all cities have experienced the recent improvements. In mid-February, Beijing saw a spike in pollution due to local weather patterns trapping air in the region.

The drop in air pollution and carbon emissions is also likely to disappear as Chinese industry ramps up again in an attempt to offset its economic losses.

"If you think back to the global financial crisis, the immediate impact was for China's emissions to fall," says Myllyvirta. "But then the government response was to roll out the biggest stimulus package in the history of mankind that then drove China's emissions and global emissions up for years."

This content is from Southern California Public Radio. View the original story at SCPR.org.

Opah fish are hauled onto a dock for sale last week in San Diego. Fishermen coming home to California after weeks at sea are finding strict anti-coronavirus measures, and nowhere to sell their catch.; Credit: Gregory Bull/AP

Commercial fishermen in the U.S. who have already faced challenges in recent years to make it in an increasingly globalized and regulated industry, are now struggling to find customers during the coronavirus crisis.

"This is totally unprecedented. This is the biggest crisis to hit the fishing industry ever, no question about that," Noah Oppenheim, executive director of The Pacific Coast Federation of Fishermen's Associations told NPR in a phone interview. The federation is a trade association representing commercial fishermen along the West Coast.

On Tuesday, seafood industry leaders, processors and fishermen sent a letter to House and Senate leaders requesting $4 billion in aid for the industry.

The closings of restaurants due to the coronavirus pandemic has hit commercial fishermen particularly hard.

An estimated 50% to 60% of wild seafood caught in the U.S. is exported, says Oppenheim. Those international markets have dried up. He says, of the seafood that's not exported, around 80% of that is sold to restaurants.

"Both of those sectors of the seafood economy are largely nonfunctional at the moment, so we're going to have to make up for approximately 90% of our markets ... through either new supply pipelines or new sets of customers."

Jerid Rold, a fishermen in Moss Landing, Calif., tells NPR, he's been out of work for a month, since South Korea stopped taking imports of hagfish. Further damaging profits, Dungeness crab prices on the West Coast have fallen from up to $7 dollars a pound to $2, says Oppenheim.

In Eureka, Calif., "there are no buyers purchasing products at the harbor there. You can't move the Dungeness crab out of the Humboldt bay," Oppenheim said. "It's actually extraordinary how similar these impacts are playing out across the country. They are palpable, they are profound and they are severe."

On the North Atlantic coast, Sam Rosen, a 30-year-old lobsterman based in Vinalhaven, Maine, said he and others are "selling lobster for amounts they shouldn't be sold for."

That's been close to $2.50 a pound, compared to a usual $10 a pound this time of year, Rosen said.

"It's definitely a shock to the system," Rosen said. "This is uncharted territory right now. I don't think anyone thought it was going to be as bad as it's getting."

If aid isn't provided to fishermen soon, "I think we could see hundreds to thousands of fishermen leave the industry nationwide," Oppenheim said.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Texas Gov. Greg Abbott signed an executive order banning all elective medical procedures, including abortions, during the coronavirus outbreak. The ban extends to medication abortions.; Credit: Eric Gay/AP

Governors across the country are banning elective surgery as a means of halting the spread of the coronavirus. But in a handful of states that ban is being extended to include a ban on all abortions.

So far the courts have intervened to keep most clinics open. The outlier is Texas, where the U.S. Court of Appeals for the Fifth Circuit this week upheld the governor's abortion ban.

Four years ago, Texas was also the focus of a fierce legal fight that ultimately led to a U.S. Supreme Court ruling in which the justices struck down a Texas law purportedly aimed at protecting women's health. The court ruled the law was medically unnecessary and unconstitutional.

Now Texas is once again the epicenter of the legal fight around abortion. In other states--Ohio, Iowa, Alabama, and Oklahoma--the courts so far have sided with abortion providers and their patients.

Not so in Texas where Gov. Greg Abbott signed an executive order barring all "non-essential" medical procedures in the state, including abortion. The executive order was temporarily blocked in the district court, but the Fifth Circuit subsequently upheld the governor's order by a 2-to-1 vote, declaring that "all public constitutional rights may be reasonably restricted to combat a public health emergency."

"No more elective medical procedures can be done in the state because of the potential of needing both people ... beds and supplies, and obviously doctors and nurses," said Texas Attorney General Ken Paxton in an interview with NPR.

'Exploiting This Crisis'

Nancy Northrup, CEO of the Center for Reproductive Rights, sees things very differently. "It is very clear that anti-abortion rights politicians are shamelessly exploiting this crisis to achieve what has been their longstanding ideological goal to ban abortion in the U.S.," she said.

Paxton denies that, saying Texas "is not targeting any particular group."
The state's the "only goal is to protect people from dying," he said.

Yet the American Medical Association just last week filed a brief in this case in support of abortion providers, as did 18 states, led by New York, which is the state that has been the hardest hit by the coronavirus.

They maintain that banning abortion is far more dangerous,because it will force women to travel long distances to get one. A study from the Guttmacher Institute found that people seeking abortions during the COVID-19 outbreak would have to travel up to 20 times farther than normal if states successfully ban abortion care during the pandemic. The AMA also notes that pregnant women do not stop needing medical care if they don't get an abortion.

Northrup, of the Center for Reproductive Rights, sees this as more evidence that the ban is a calculated move by the state: what "puts the lie to this is the fact that they're trying to ban medication, abortion as well; that's the use of pills for abortion.

"Those do not need to take place in a clinic and they can be done, taken effectively by tele-medicine. So it shows that the real goal here, tragically, is shutting down one's right to make the decision to end the pregnancy, not a legitimate public health response."

'I Was Desperate'

Affidavits filed in the Texas case tell of harrowing experiences already happening as the result of the Texas ban. One declaration was filed by a 24-year-old college student. The week she lost her part-time job as a waitress, she found out she was pregnant. She and her partner agreed they wanted to terminate the pregnancy, and on March 20 she went to a clinic in Forth Worth alone; because of social distancing rules, her partner was not allowed to go with her.

Since she was 10 weeks pregnant, still in her first trimester, she was eligible for a medication abortion. Under state law, she had to wait 24 hours before getting the pills at the clinic, but the night before her scheduled appointment, the clinic called to cancel because of Abbott's executive order.

He partner was with her and we "cried together," she wrote in her declaration. "I couldn't risk the possibility that I would run out of time to have an abortion while the outbreak continued," and it "seemed to be getting more and more difficult to travel."

She made many calls to clinics in New Mexico and Oklahoma. The quickest option was Denver--a 12-hour drive, 780-mile drive from where she lives. Her partner was still working, so her best friend agreed to go with her. They packed sanitizing supplies and food in the car for the long drive and arrived at the Denver Clinic on March 26, where she noticed other cars with Texas plates in the parking lot, according to the affidavit.

At the clinic, she was examined, given a sonogram again, and because Colorado does not have a 24-hour waiting requirement, she was given her first abortion pill without delay and told she should try to get home within 30 hours to take the second pill.

She and her friend then turned around to go home. They were terrified she would have the abortion in the car, and tried to drive through without taking breaks. But after six hours, when it turned dark they were so exhausted they had to stop at a motel to catch some sleep. The woman finally got home and took the second pill just within the 30-hour window.

She said that despite the ordeal she was grateful she had the money, the car, the friend, and the supportive partner with a job, to make the abortion possible. Others will not be so lucky, she wrote. But "I was desperate and desperate people take desperate steps to protect themselves."

A 'Narrative' Of Choice

Paxton, the Texas attorney general, does not seem moved by the time limitations that pregnancy imposes, or the hardships of traveling out of state to get an abortion. He told NPR "the narrative has always been 'It's a choice' ... that's the whole narrative. I'm a little surprised by the question, given that's always been the thing."

On Thursday abortion providers and their patients returned to the district court in Texas instead of appealing directly to the U.S. Supreme Court to overturn the Fifth Circuit's ruling from earlier this week. The district court judge, who originally blocked the governor's ban, instead narrowed the governor's order so that medical abortions--with pills--would be exempt from the ban, as well as abortions for women who are up against the state-imposed deadline. Abortions in Texas are banned after 22 weeks.

In the end, though, this case may well be headed to the U.S. Supreme Court. And because of the addition of two Trump appointees since 2016--the composition of the court is a lot more hostile to abortion rights.

This content is from Southern California Public Radio. View the original story at SCPR.org.

As millions of Americans have lost their jobs, Congress is trying to figure out what to do to help those who have also lost their health insurance.; Credit: South_agency/Getty Images

Mayra Jimenez had just lost the job she loved — and the health insurance that went along with it.

The 35-year-old San Francisco server needed coverage. Jimenez has ulcerative colitis, a chronic condition. Just one of her medications costs $18,000 per year.

"I was just in panic mode, scrambling to get coverage," Jimenez said.

A recent estimate suggests the pandemic has cost more than 9 million Americans both their jobs and their health insurance.

"Those numbers are just going to go up," MIT economist Jon Gruber said. "We've never seen such a dramatic increase in such a short period of time."

House Democrats introduced a bill in mid-April to help the millions of people, like Jimenez, who find themselves unsure of where to turn.

The Worker Health Coverage Protection Act would fully fund the cost of COBRA, a program that allows workers who leave or lose a job to stay on their former employer's insurance plan. COBRA currently requires workers to pay for their entire premium, including their employer's share.

The Worker Health Coverage Protection Act is one bill being considered as Congress tries to figure out what to do about the very real health care gap for those millions who have lost their jobs. Sponsors of the COBRA legislation say they hope their plan gets rolled into the next relief bill. But it's unclear when, how and whether the problem will get addressed in upcoming coronavirus relief measures.

Jimenez learned COBRA would run her $426 a month.

"I was kind of shocked to hear the number," she said. "That's almost half my rent."

The idea of allowing laid-off workers to stick with their coverage at no cost in a pandemic has clear appeal, says Gruber.

But he warns, "COBRA is expensive, and for many employees, it won't be there."

Only workers who get insurance through their employer are eligible for COBRA, leaving out more than half of the 26 million who have lost jobs in the last few weeks. Many of the industries hit hardest by COVID-19, including retail and hospitality, are among those least likely to offer employees insurance.

And even if someone had insurance through work, the person loses COBRA coverage if the former employer goes out of business.

Funding COBRA costs, federal dollars also wouldn't go as far as they could. Unpublished Urban Institute estimates show that an employer plan costs, on average, about 25% more than a Gold plan on the Affordable Care Act exchanges.

"We need to be all hands on deck, spending whatever we can to help people," Gruber said. "But that doesn't mean we shouldn't be thinking about efficient ways to do it."

Congress has tried this move before. In response to the Great Recession, lawmakers tucked a similar COBRA subsidy into the massive stimulus bill a decade ago. That legislation paid for 65% of COBRA premiums, leaving laid-off workers to cover the rest.

A federally commissioned study found that COBRA enrollment increased by just 15%. Mathematica senior researcher and study co-author Jill Berk said workers skipped the subsidy for two main reasons.

First, only about 30% of eligible workers even knew the subsidy existed.

"For those that were aware," Berk said, "their overwhelming response was that COBRA was still too expensive."

At that time, the average premium for a single worker — even with the subsidy — ran about $400 per month for a worker with family coverage.

"When you're actually facing those choices, choosing between rent and food and other bills," Berk said, "that COBRA bill looks quite high."

Berk's team also discovered that people who reported using the subsidy were four times more likely to have a college degree and a higher income than those who passed on it. In other words, Berk found that the COBRA subsidy was least helpful to those with the greatest need.

Several economists, including Gruber, and some Democrats in Washington are kicking around alternatives to COBRA. Among their ideas is a plan to have the federal government pick up more of a person's premium and other expenses on the Affordable Care Act exchanges. Another proposal would extend ACA subsidies to people who earn too much to qualify for any aid and to lower-income people who live in states yet to expand Medicaid.

Compared with funding COBRA, beefing up ACA subsidies could potentially help millions more people, including the pool of laid-off workers who did not get health insurance from their employer.

The ACA ties subsidies to people's income, giving more help to those at the bottom end of the wage scale and spending less on those who are better off. In contrast, the current COBRA plan would cover 100% of COBRA for everyone, regardless of the person's income.

There are some downsides to this approach. Making ACA subsidies more generous could end up costing the federal government more overall, because it gives more help to a lot more people.

Chris Holt from the American Action Forum, a conservative think tank, points out that the ACA already increases federal support when people's earnings fall and questions how much more of the tab Washington should pick up.

"If that subsidy would have been good enough for someone six months ago, why is it not good enough now?" he asked.

Maybe the biggest challenge to building on the ACA: The 10-year-old law remains a political football.

"There's just so much both emotion and, frankly, bitterness tied up in debates," Holt said, adding that this makes it hard to move anything forward.

Holt notes that COBRA is not free of political hang-ups either. He expects a fight over whether subsidy money can be spent on employer plans that cover abortion services, for example.

Holt and Gruber agree that perhaps the easiest idea is to leave the ACA alone with one minor tweak: allow people to take the ACA subsidy they're already eligible for and use it on COBRA if they choose.

As for Jimenez, she did not have time to wait for Congress. She brought in too much from unemployment to qualify for Medicaid. And she couldn't afford COBRA, so she picked out a plan on the ACA exchange, where she's eligible for generous existing subsidies. It will cost her $79.17 per month, and she gets to keep her doctors. Not everyone does.

This is the first time she has ever purchased insurance on her own, rather than gotten it through work — and that has delivered one other unexpected benefit.

"Freedom," Jimenez said. "It feels so freeing to take charge of my health care and to know that no one can take this away from me. I don't have to rely on a job to give me what they want to give me. I can make my own choices."

Policymakers, providers, employers and health-industry executives have been fighting over whether the United States should tie insurance to work since the end of World War II.

Subsidizing COBRA preserves the status quo, while doubling down on the ACA might just start to drive a real wedge between work and health insurance.

As states begin reopening businesses, some laid-off workers will get back their jobs, as well as their insurance. But many will remain unemployed and uninsured. A decade ago, faced with the same challenge, Congress chose to subsidize COBRA. It proved to be a narrow solution with limited impact.

Lawmakers now have the ACA at their disposal, a tool that may be a better fit for this moment. Whether they choose to use it may be a choice grounded more in political realism than policy idealism.

Dan Gorenstein is the creator and co-host of the Tradeoffs podcast, and Leslie Walker is a producer on the show, which ran a version of this story on April 23.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Deputy Chief Patricia Cassidy of the Jersey City Police Department has blood drawn to test for coronavirus antibodies in Jersey City, N.J., on Monday.; Credit: Seth Wenig/AP

The Food and Drug Administration is stiffening its rules to counteract what some have called a Wild West of antibody testing for the coronavirus.

These tests are designed to identify people who have been previously exposed to the virus. The FDA said more than 250 developers have been bringing products to the market in the past few weeks.

In a rush to make antibody tests available as quickly as possible, the FDA had set a low standard for these tests. Manufacturers were supposed to submit their own information about the accuracy of their wares, but the agency had no standards for what would be acceptable. Companies weren't allowed to claim the tests were authorized by the FDA, under initial guidance issued in mid-March.

Now the FDA is telling manufacturers that if they want their tests to remain on the market, they must meet minimum quality standards and submit a request for emergency use authorization, a temporary route to market for unapproved products when others aren't available. The EUA involves a lower standard than the usual FDA clearance or approval.

The FDA said 12 manufacturers have already opted to request EUA's for their products. More than 100 other producers have been talking to the agency about using this process, said FDA Commissioner Stephen Hahn. He spoke on a press call Monday. Companies have 10 days to submit that request.

"Our expectation is that those who can't [meet the new standard] will withdraw their products from the market and we will be working with them to help them do that," he said.

These tests are now so widespread that people can order them from lab giants Quest or LabCorp. The tests can cost more than $100. Though the FDA's original guidance calls for these tests to be run by a certified lab, the kits themselves are simple to use and have been readily available.

Despite the enthusiasm surrounding these tests, they have substantial limitations. Though people who test positive for antibodies have in most cases been exposed to the coronavirus, scientists don't know whether that means those people are actually immune from the coronavirus, and if so for how long.

"Whether this is the ticket for someone to go back to work [based solely on an antibody test result], my opinion on that would be no," Hahn said.

The tests may be more useful when combined with information from a standard coronavirus diagnostic test, or in someone who has symptoms, or if the results have been confirmed with a different antibody test. That "would dramatically increase the accuracy of those tests," said Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health

Antibodies are a potentially valuable research tool, and can be used to determine the prevalence of a disease in a population. In that circumstance, individual false results are less important. New York State used antibody tests to determine that about 20 percent of people in New York City have already been exposed to the coronavirus.

In California, researchers have attempted to measure the prevalence of the coronavirus in Los Angeles County and Santa Clara County in the Bay Area. Those unpublished results have garnered criticism because even a test that's more than 99 percent accurate can produce many false positive results when used to survey hundreds or thousands of people.

In the face of this criticism, the authors of the Santa Clara study have posted revised results acknowledging the high degree of uncertainty in their findings. Those findings haven't been peer-reviewed.

The emergency use authorization is only valid during the time of the national emergency. "Once the national emergency ends, the EUA authorizations end as well," Shuren said. Companies that want to keep marketing these tests will need to get them approved through the regular, more stringent FDA process.

FDA officials say they will continue to crack down on companies that falsely claim their tests are approved by the FDA, or that market them for home use, which isn't currently allowed.

You can contact NPR Science Correspondent Richard Harris at rharris@npr.org.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Coronavirus deaths in the U.K. have passed those in Italy. Workers in the intensive care unit at the Royal Papworth Hospital in Cambridge are shown gearing up to care for COVID-19 patients.; Credit: Neil Hall/AP

Over 32,000 people have died from the new coronavirus in the United Kingdom, according to the Office for National Statistics, marking the first time in the pandemic that it has led Europe in the number of deaths.

The country has surpassed Italy in COVID-19 deaths. The U.S. still leads the world in the highest number of coronavirus deaths; over 70,270 had died from the disease as of Tuesday.

The number of total deaths recorded in the U.K. is "higher than we would wish, I think is all I can say," Angela McLean, chief scientific adviser of Ministry of Defence said during the country's press briefing Tuesday.

McLean also emphasized that deaths in U.K. care homes have been steadily rising and said the trend was something the country "need[s] to get to grips with."

"I don't think we'll get a real verdict on how well countries have done until the pandemic is over," British Foreign Secretary Dominic Raab said Tuesday. "And particularly until we have comprehensive international data on all causes of mortality."

Since different countries collect and report coronavirus data using different methods, the comparisons between regions are not perfect. As more time passes and more tests are conducted and more data comes in, coronavirus death rates will become more precise.

The peak in deaths comes as other European countries, including Italy and Spain, are easing shelter-in-place restrictions, while U.K. Prime Minister Boris Johnson is expected to modify Britain's orders in the next week.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Two workers approach the entrance to Life Care Center in Kirkland, Wash., on March 13. An association that represents nursing homes is asking for billions of dollars in federal relief funds to cope with the coronavirus crisis.; Credit: Ted S. Warren/AP

With more than 11,000 resident deaths, nursing homes have become the epicenter of the COVID-19 crisis. Now, they're asking the federal government for help — $10 billion worth of help.

The American Health Care Association, the trade organization for most nursing homes, called the impact on long-term care facilities "devastating." In a letter sent this week to the Federal Emergency Management Agency and Health and Human Services Secretary Alex Azar, they ask for the federal government to designate relief funding from the CARES Act for nursing homes the way it has for hospitals.

The money would be used for personal protective equipment, salaries for expanded staff, and hazard pay. In addition, some of the funds would make up lost revenue for nursing homes that have been unable to admit new residents because of the outbreak.

The AHCA also wants nursing homes to have more access to testing and some members of Congress want that too. This week, 87 members of the House of Representatives sent their own letter to Azar, as well as to Seema Verma, the administrator of the Centers for Medicare and Medicaid Services, which regulates nursing homes. The letter asks those agencies to direct states — which have received billions of dollars for increased testing — to give priority to long-term care facilities.

The letter also notes that nursing homes are now required to report their numbers of COVID-19 infections and deaths to the Centers for Disease Control and Prevention, but that they can't meaningfully do this unless they can test everyone in the facility.

Democrats in both the House and the Senate have also introduced legislation intended to make things safer for both nursing home staff and residents. The bill would require nursing homes to take a range of actions, from providing better infection prevention, to supplying sufficient protective gear, to protecting a resident's right to return to the nursing home after they've been treated for COVID-19 at a hospital.

This content is from Southern California Public Radio. View the original story at SCPR.org.

; Credit: Alyson Hurt/NPR

To safely phase out social distancing measures, the U.S. needs more diagnostic testing for the coronavirus, experts say. But how much more?

The Trump administration said on April 27 the U.S. will soon have enough capacity to conduct double the current amount of testing for active infections. The country has done nearly 248,000 tests daily on average in the last seven days, according to the nonprofit Covid Tracking Project. Doubling that would mean doing around 496,000 a day.

Will that be enough? What benchmark should states try to hit?

One prominent research group, Harvard's Global Health Institute, proposes that the U.S. should be doing more than 900,000 tests per day as a country. This projection, released Thursday, is a big jump from its earlier projection of testing need, which was between 500,000 and 600,000 daily.

Harvard's testing estimate increased, says Ashish Jha, director of the Global Health Institute, because the latest modeling shows that the outbreak in the U.S. is worse than projected earlier.

"Just in the last few weeks, all of the models have converged on many more people getting infected and many more people [dying]," he says.

But each state's specific need for testing varies depending on the size of its outbreak, explains Jha. The bigger the outbreak, the more testing is needed.

Thursday Jha's group at Harvard published a simulation that estimates the amount of testing needed in each state by May 15. In the graphic below, we compare these estimates with the average numbers of daily tests states are currently doing. (Jump to graphic)

Two ways to assess whether testing is adequate

To make their state-by-state estimates, the Harvard Global Health Institute group started from a model of future case counts. They calculated how much testing would be needed for a state to test all infected people and any close contacts they may have exposed the virus. (The simulation estimates testing 10 contacts on average.)

"Testing is outbreak control 101, because what testing lets you do is figure out who's infected and who's not," Jha says. "And that lets you separate out the infected people from the non infected people and bring the disease under control."

This approach is how communities can prevent outbreaks from flaring up. First, test all symptomatic people, then reach out to their close contacts and test them, and finally ask those who are infected or exposed to isolate themselves.

Our chart also shows another testing benchmark for each state: the ratio of tests conducted that come back positive. Communities that see around 10% or fewer positives among their test results are probably testing enough, the World Health Organization advises. If the rate is higher, they're likely missing a lot of active infections.

What is apparent from the data we present below is that many states are far from both the Harvard estimates and the 10% positive benchmark.

Just nine states are near or have exceeded the testing minimums estimated by Harvard; they are mostly larger, less populous states: Alaska, Hawaii, Montana, North Dakota, Oregon, Tennessee, Utah, West Virginia and Wyoming.

Several states with large outbreaks — New York, Massachusetts and Connecticut among others — are very far from the minimum testing target. Some states that are already relaxing their social-distancing restrictions, such as Georgia, Texas and Colorado, are far from the target too.

Jha offers several caveats about his group's estimates.

Estimates are directional not literal

Researchers at the Global Health Initiative at Harvard considered three different models of the U.S. coronavirus outbreak as a starting point for their testing estimates. They found that while there was significant variation in the projections of outbreak sizes, all the models tend to point in the same direction, i.e. if one model showed that a state needed significantly more testing, the others generally did too.

The model they used to create these estimates is the Youyang Gu COVID-19 Forecasts, which they say has tracked closely with what's actually happened on the ground. Still the researchers caution, these numbers are not meant to be taken literally but as a guide.

If social distancing is relaxed, testing needs may grow

The Harvard testing estimates are built on a model that assumes that states continue social distancing through May 15. And about half of states have already started lifting some of those.

Jha says, that without the right measures in place to contain spread, easing up could quickly lead to new cases.

"The moment you relax, the number of cases will start climbing. And therefore, the number of tests you need to keep your society, your state from having large outbreaks will also start climbing," warns Jha.

Testing alone is not enough

A community can't base the decision that it's safe to open up on testing data alone. States should also see a consistent decline in the number of cases, of two weeks at least, according to White House guidance. If their cases are instead increasing, they should assume the number of tests they need will increase too.

And Jha warns, testing is step one, but it won't contain an outbreak by itself. It needs to be part of "a much broader set of strategies and plans the states need to have in place" when they begin to reopen.

In fact, his group's model is built on the assumption that states are doing contact tracing and have plans to support isolation for infected or exposed people.

"I don't want anybody to just look at the number and say, we meet it and we're good to go," he says. "What this really is, is testing capacity in the context of having a really effective workforce of contact tracers."

The targets are floors not goals

States that have reached the estimated target should think of that as a starting point.

"We've always built these as the floor, the bare minimum," Jha says. More testing would be even better, allowing states to more rapidly tamp down case surges.

In fact, other experts have proposed the U.S. do even more testing. Paul Romer, a professor of economics at New York University proposed in a recent white paper that if the U.S. tested every resident, every two weeks, isolating those who test positive, it could stop the pandemic in its tracks.

Jha warns that without sufficient testing, and the infrastructure in place to trace and isolate contacts, there's a real risk that states — even those with few cases now — will see new large outbreaks. "I think what people have to remember is that the virus isn't gone. The disease isn't gone. And it's going to be with us for a while," he says.

Daniel Wood contributed to this report.

This content is from Southern California Public Radio. View the original story at SCPR.org.

The East Bay Municipal Utility District Wastewater Treatment Plant in Oakland, California. Stanford researchers are testing sewage in hopes of tracking the emergence and spread of COVID-19 outbreaks.; Credit: Justin Sullivan/Getty Images

With coronavirus testing still lagging behind targets, many health officials are searching for other ways to assess the spread of the outbreak. One possibility? Looking at what we flush.

SARS-Cov-2 is often spread through sneezes and coughs, but it also leaves the human body through our waste. Scientists around the world are now testing sewage for the virus, using it as a collective sample to measure infection levels among thousands of people.

While the field of "wastewater epidemiology" existed before the coronavirus pandemic began, it's now rapidly expanding in the hope that it can become a front-line public health tool.

"Normally when I tell people I work with poo, they're not super interested," Stephanie Loeb, a post-doctoral researcher at Stanford University, told NPR in an interview over Skype. But, she says: "There's really a lot of information in our waste."

In the basement of a university building, Loeb pulls samples from freezers filled with vials of raw sewage, collected regularly from 25 wastewater treatment plants around California. Each is a snapshot of that community's health.

"It's this perfect mix, you know," says Krista Wigginton, a professor of environmental engineering at the University of Michigan, also working on the Stanford project. "The entire community is putting samples in at the same time."

She says by the time the virus reaches wastewater treatment plants, it's still possible to read its RNA.

"These are virus particles that are mostly intact, but that are no longer infective," Wigginton says. "That's what it looks like at this point."

The idea is that measuring overall virus levels in sewage over time could indicate whether an outbreak is growing or shrinking, potentially showing that trend earlier than patient testing would.

"That's a real-time measurement of what's happening in the community," says Wigginton. "Whereas some other tools we have, like the number of confirmed cases in clinics, sometimes those are delayed by quite a bit of time because people don't go get checked until maybe their illness has progressed by quite a bit."

The approach is already used for other diseases, such as polio. Health officials are working to eradicate polio around the globe and in Israel, an outbreak was spotted early through the wastewater system.

Stanford University isn't the only group working on coronavirus detection in sewage.

"We have a lot of nicknames," says Newsha Ghaeli, co-founder of the start-up Biobot. "I think some of our customers joke around that we're the 'sewer girls.'"

Biobot is currently testing sewage from about 150 communities across the U.S. Originally, the company was using sewage to monitor the opioid crisis, but quickly started offering coronavirus testing.

"It really caught fire," says Ghaeli. "Within ten days, we hit internal capacity."

Ghaeli says in some cities, they've been able to detect coronavirus in sewage the same week the first cases appeared. Other projects in France and the Netherlands have produced similar results.

In a more challenging scientific feat, the team is also working to estimate the number of individuals who have coronavirus in a community, based on the levels found in sewage.

Calculating that depends on knowing how much virus individuals shed, and some people seem to shed for a longer time than others, complicating the math. Other things could also affect the virus levels, such as how long it takes for the wastewater to reach the treatment plant and rainy weather, which causes runoff to flow in the sewage system in some communities, diluting the samples.

"There's a lot of research that needs to be done before we can say this number in wastewater means this many cases in the community," says Wigginton.

The advantage of testing sewage is that it may capture individuals who are less likely to go to a doctor's offices.

"Every person that is using the toilet has a voice," says Mariana Matus, Biobot's other cofounder. "And they can be taken into account for public health resources and prioritization of resources."

While it's still early in the technology's development, some see it being helpful in detecting new waves of the outbreak.

"I think it is potentially a new role that utilities can play," says Doug Yoder, deputy director of the Miami-Dade Water and Sewer Department in Florida, which serves 2.3 million people. "There has been, at the community level, not a whole lot of data about conditions community-wide."

Miami-Dade County has been sending sewage samples to Biobot for six weeks now, which have shown their virus levels going up and down a bit.

"We've seen in a couple instances the virus counts increase by a factor of six," he says. "And then the week following, it went back down. This data may not yet be ready for primetime in terms of community decision-making, but it has potential and promise for being able to see trends."

Health officials are eager for the information, he says, as one more way to gauge what's really happening with their local outbreak.

This content is from Southern California Public Radio. View the original story at SCPR.org.